Q&A: Novavax Covid vaccine – all you need to know

Boris Johnson visiting the Fujifilm Diosynth Biotechnologies plant in Billingham, Teesside, where the protein antigen component of the Novavax vaccine will be made (Scott Heppell/PA)

The British government has agreed a deal with pharmaceutical giant GlaxoSmithKline (GSK) on the manufacture of up to 60 million doses of the Novavax coronavirus vaccine.

Here is what we know: